Breast Cancer Trial, Recruiting NCT07095569 Sponsor: National Cancer Institute, Egypt Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07095569
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 65 years old.
  • People whose general health falls within a moderate range as assessed by a medical professional (known as ASA physical status II–III — confirm with trial site).
  • People who have shoulder pain following mastectomy and radiation treatment.
  • People whose body mass index (BMI) is between 20 and 40 kg/m².

Who may not be able to join:

  • People who do not wish to take part in the trial.
  • People with a known allergy or medical reason to avoid the medications being used in the study.
  • People who are pregnant.
  • People who have had a heart attack recently.
  • People whose blood pressure or circulation is not stable.
  • People with an active infection, either in a specific area of the body or throughout the whole body.
  • People with a diagnosed psychiatric illness.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +201111068300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cancer Institute, Egypt
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 August 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Assess the changes in NPRS (numerical pain rating scale) for assessment of pain relief which will be recorded before treatment and at 1 month, 2 months and 3-month intervals following treatment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov